Lazari Capital Management’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$642K Buy
47,421
+1,300
+3% +$19.3K 0.2% 87
2026
Q1
$709K Hold
46,121
0.25% 73
2025
Q4
$832K Sell
46,121
-550
-1% -$9.46K 0.28% 61
2025
Q3
$752K Buy
46,671
+200
+0.4% +$2.92K 0.25% 66
2025
Q2
$506K Buy
46,471
+1,003
+2% +$11.2K 0.19% 79
2025
Q1
$567K Buy
45,468
+1
+0% +$16 0.23% 72
2024
Q4
$900K Hold
45,467
0.36% 44
2024
Q3
$371K Sell
45,467
-8,000
-15% -$54.3K 0.16% 91
2024
Q2
$364K Buy
53,467
+3,300
+7% +$22.6K 0.16% 91
2024
Q1
$251K Buy
50,167
+2,450
+5% +$5.22K 0.14% 86
2023
Q4
$105K Buy
47,717
+700
+1% +$1.67K 0.06% 114
2023
Q3
$116K Buy
47,017
+4,000
+9% +$19.1K 0.07% 112
2023
Q2
$336K Buy
+43,017
New +$307K 0.19% 74

Other funds holding MESO

Lazari Capital Management's MESO Position: Q2 2026 in Review

Lazari Capital Management increased its Mesoblast (MESO) stake by 2.8% in Q2 2026, buying an estimated $19.3K and bringing the position to 47,421 shares worth $642K. The position accounts for 0.2% of the portfolio, ranked #87.

Lazari Capital Management first reported a position in MESO in Q2 2023 and has held it in 13 quarters since. The position peaked at $900K in Q4 2024. 13 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • Lazari Capital Management held 47,421 shares of Mesoblast worth $642K as of Q2 2026.
  • Lazari Capital Management bought 1,300 Mesoblast shares in Q2 2026, an estimated $19.3K.
  • Mesoblast made up 0.2% of Lazari Capital Management's portfolio in Q2 2026, its #87 holding.
  • Lazari Capital Management first reported a position in Mesoblast in Q2 2023 and has held it in 13 quarters since.
  • Lazari Capital Management's Mesoblast position peaked at $900K in Q4 2024.
  • 13 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on Lazari Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.